Smith Cynthia

Smith Cynthia is listed in filings as Director at Agios Pharmaceuticals, Inc. - Common Stock (AGIO). This profile follows SEC Form 4 activity through Aug 13, 2025, including 9 public disclosures. Recent filings connect the profile to Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO), Spero Therapeutics, Inc. (SPRO), Protara Therapeutics, Inc. (TARA), and Akebia Therapeutics, Inc. (AKBA). The current snapshot covers public activity from Apr 21, 2025 to Aug 13, 2025. Reported amounts are shown as $559.8K to $210.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.